Price T Rowe Associates Inc Adaptive Biotechnologies Corp Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 155,229 shares of ADPT stock, worth $561,928. This represents 0.0% of its overall portfolio holdings.
Number of Shares
155,229
Previous 292,884
47.0%
Holding current value
$561,928
Previous $1.44 Million
65.25%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ADPT
# of Institutions
200Shares Held
146MCall Options Held
2.6KPut Options Held
143K-
Viking Global Investors LP30MShares$109 Million0.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$46.6 Million0.0% of portfolio
-
Matrix Capital Management Company, LP Waltham, MA11.6MShares$41.9 Million0.35% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$40.5 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.6MShares$38.2 Million0.24% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $517M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...